Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Clinical Infectious Diseases (CID)
Published October 7, 2026
Does the DOOR Account for Post-randomization Treatment Modification or Incorporate It?
October 8, 2026
Medspoke
Medspoke
The Lancet Infectious Diseases
Published October 7, 2026
00:00
--:--
Evidence of artemisinin partial resistance in Zambia: a molecular epidemiology and clinical study.
October 8, 2026
Share
Evidence of artemisinin partial resistance in Zambia: a molecular epidemiology and clinical study.
https://www.medspoke.co/channel_journal?id=807&tap_id=15235
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Diabetes Care
Published October 7, 2026
Diabetes Care of Children With Type 1 Diabetes at School: Factors Related to the Choice of Care L...
October 8, 2026
Why are you reporting this TALK?